Walking after spinal cord injury: Evaluation, treatment, and functional recovery

Archives of Physical Medicine and Rehabilitation

Volumn 80, Issue 2, 1999, Pages 225-235

  Barbeau, Hugues ^a   Ladouceur, Michel ^a   Norman, Kathleen E ^a   Pépin, André ^a   Leroux, Alain ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; BACLOFEN; BENZOCAINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BOTULINUM TOXIN; CHLORPROMAZINE; CLONIDINE; CYPROHEPTADINE; DANTROLENE; DIAZEPAM; GLYCINE; LIDOCAINE; MORPHINE; PROGABIDE; PROPRANOLOL; THREONINE; TIZANIDINE;

DISABILITY; DRUG EFFICACY; FEEDBACK SYSTEM; HUMAN; NONHUMAN; ORTHOSIS; PARAPLEGIA; QUADRIPLEGIA; REVIEW; SPASTICITY; SPINAL CORD INJURY; WALKING SPEED;

EID: 0033016749     PISSN: 00039993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-9993(99)90126-0     Document Type: Review

References (153)

1. Campos da Paz A, Beraldo PS, Almeida MC, Neves EG, Alves CM, Khan P. Traumatic injury to the spinal cord. Prevalence in Brazilian hospitals. Paraplegia 1992;30:636-40.
2. Dincer F, Oflazer A, Beyazova M, Celiker R, Basgoze O, Altioklar K. Traumatic spinal cord injuries in Turkey. Paraplegia 1992;30:641-6.
3. Dixon GS, Danesh JN, Caradoc-Davies TH. Epidemiology of spinal cord injury in New Zealand. Neuroepidemiology 1993;12: 88-95.
4. Go BK, DeVivo MJ, Richards JS. The epidemiology of spinal cord injury. In: Stover SL, DeLisa JA, Whiteneck GG, editors. Spinal cord injury: clinical outcomes from the model systems. Gaithersburg (MD): Aspen; 1995. p. 21-55.
5. Knutsdottir S. Spinal cord injuries in Iceland 1973-1989. A follow up study. Paraplegia 1993;31:68-72.
6. Shingu H, Ohama M, Ikata T, Katoh S, Akatsu T. A nationwide epidemiological survey of spinal cord injuries in Japan from January 1990 to December 1992. Paraplegia 1995;33:183-8.
7. Silberstein B, Rabinovich S. Epidemiology of spinal cord injuries in Novosibirsk, Russia. Paraplegia 1995;33:322-5.
8. Soopramanien A. Epidemiology of spinal injuries in Romania. Paraplegia 1994;32:715-22.
9. Frankel HL, Hancock DO, Hyslop G, Melzak J, Michaelis LS, Ungar GH, et al. The value of postural reduction in the initial management of closed injuries of the spine with paraplegia and tetraplegia. Paraplegia 1969;7:179-92.
10. Bracken MB, Shepard MJ, Collins WF, Holford TR, Baskin DS, Eisenberg HM, et al. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the Second National Acute Spinal Cord Injury Study (NASCIS). New Engl J Med 1990;322:1405-11.
11. Bracken MB, Shepard MJ, Collins WF Jr, Holford TR, Young W, Baskin DS, et al. Methylprednisolone or naloxone treatment after acute spinal cord injury: 1-year follow-up data. Results of the second National Acute Spinal Cord Injury Study. J Neurosurg 1992;76:23-31.
12. Geisler FH, Dorsey FC, Coleman WP. Recovery of motor function after spinal-cord injury - a randomized, placebocontrolled trial with GM-1 ganglioside. N Engl J Med 1991;324: 1829-38.
13. Faden AI. Pharmacological treatment of central nervous system trauma. Pharmacol Toxicol 1996;78:12-7.
14. Rhoney DH, Luer MS, Hughes M, Hatton J. New pharmacologic approaches to acute spinal cord injury. Pharmacotherapy 1996;16: 382-92.
15. Knutsson E, Richards CL. Different types of disturbed motor control in gait of hemiparetic patients. Brain 1979;102:405-30.
16. Dietz V, Quintern J, Berger W. Electrophysiological studies of gait in spasticity and rigidity: evidence that altered mechanical properties of muscle contribute to hypertonia. Brain 1981;104:431-49.
17. Conrad B, Benecke R, Carnehl J, Hohne J, Meinck HM. Pathophysiological aspects of human locomotion. Adv Neurol 1983;39:717-26.
18. Wainberg M, Barbeau H, Gauthier S. Quantitative assessment of the effect of cyproheptadine on spastic paretic gait: a preliminary study. J Neurol 1986;233:311-4.
19. Wagenaar RC, Beek WJ. Hemiplegic gait: a kinematic analysis using walking speed as a basis. J Biomech 1992;25:1007-15.
20. Pépin A, Barbeau H. Effects of treadmill speed and incline on the walking pattern of normal and spastic paretic subjects. Soc Neurosci Abstr 1992;18:860.
21. Nilsson J, Thorstensson A, Halbertsma J. Changes in leg movements and muscle activity with speed of locomotion and mode of progression in humans. Acta Physiol Scand 1985;123:457-75.
22. Conrad B, Benecke R, Meinck H-M. Gait disturbances in paraspastic patients. In: Delwaide PJ, Young RR, editors. Clinical neurophysiology in spasticity. Contribution to assessment and pathophysiology. Amsterdam: Elsevier; 1985. p. 155-74.
23. Fung J, Barbeau H. A dynamic EMG profile to quantify muscular activation disorder in spastic paretic gait. Electroencephalogr Clin Neurophysiol 1989;73:233-44.
24. Fung J, Barbeau H. Effects of conditioning cutaneomuscular stimulation on the soleus H-reflex in normal and spastic paretic subjects during walking and standing. J Neurophysiol 1994;72: 2090-104.
25. Mirbagheri MM, Kearney RE, Barbeau H, Ladouceur M. Increased reflex contributions to dynamic ankle stiffness in spastic spinal cord injured patients. In: Proceedings of the Annual International Conference of the IEEE Engineering in Medicine and Biology Society; 1996 Oct 31-Nov 3; Amsterdam. Piscataway (NJ): IEEE; 1996. p. 786.
26. Sinkjaer T, Magnussen I. Passive, intrinsic and reflex-mediated stiffness in the ankle extensors of hemiparetic patients. Brain 1994;117:355-63.
27. Dietz V, Berger W. Normal and impaired regulation of muscle stiffness in gait: a new hypothesis about muscle hypertonia. Exp Neurol 1983;79:680-7.
28. Given JD, Dewald JP, Rymer WZ. Joint dependent passive stiffness in paretic and contralateral limbs of spastic patients with hemiparetic stroke. J Neurol Neurosurg Psychiatry 1995;59: 271-9.
29. Yang JF, Fung J, Edamura M, Blunt R, Stein RB, Barbeau H. H-reflex modulation during walking in spastic paretic subjects. Can J Neurol Sci 1991;18:443-52.
30. Delwaide PJ. Human monosynaptic reflexes and presynaptic inhibition. An interpretation of spastic hyperreflexia. In: Desmedt JE, editor. Human reflexes, pathophysiology of motor systems, methodology of human reflexes. Basel: S. Karger; 1973. p. 508-22.
31. Faist M, Mazevet D, Dietz V, Pierrot-Deseilligny E. A quantitative assessment of presynaptic inhibition of Ia afferents in spastics. Differences in hemiplegies and paraplegics. Brain 1994;117:1449-55.
32. Crone C, Nielsen J, Petersen N, Ballegaard M, Hultborn H. Disynaptic reciprocal inhibition of ankle extensors in spastic patients. Brain 1994;117:1161-8.
33. Ashworth B. Preliminary trial of carisoprodol in multiple sclerosis. Practitioner 1964;192:540-2.
34. Lance JW. Symposium synopsis. In: Feldman RG, Young RR, Koella WP, editors. Spasticity: disordered motor control. Chicago: Year Book; 1980. p. 485-94.
35. Young RR, Delwaide PJ. Drug therapy. Spasticity. N Engl J Med 1981;304:28-33.
36. Wiesendanger M. Neurophysiological bases of spasticity. In: Sindou M, Abbott IR, Keravel Y, editors. Neurosurgery for spasticity. New York: Springer-Verlag; 1991. p. 15-9.
37. Young RR. Spasticity: a review. Neurology 1994;44 Suppl 9:S12-S20.
38. Meythaler JM, McCary A, Hadley MN. Prospective assessment of continuous intrathecal infusion of baclofen for spasticity caused by acquired brain injury. J Neurosurg 1997;87:415-9.
39. Nance PW, Bugaresti J, Shellenberger K, Sheremata W, Martinez-Arizala A, North American Tizanidine Study Group. Efficacy and safety of tizanidine in the treatment of spasticity in patients with spinal cord injury. Neurology 1994;44 Suppl 9:S44-S52.
40. Latash ML, Penn RD, Corcos DM, Gottlieb GL. Effects of intrathecal baclofen on voluntary motor control in spastic paresis. J Neurosurg 1990;72:388-92.
41. Maynard FM, Karunas RS, Waring WP. Epidemiology of spasticity following traumatic spinal cord injury. Arch Phys Med Rehabil 1990;71:566-9.
42. Maynard FM, Karunas RS, Adkins RH, Richards JS, Waring WPI. Management of the neuromuscular system. In: Stover SL, DeLisa JA, Whiteneck GG, editors. Spinal cord injury: clinical outcomes from the model systems. Gaithersburg (MD): Aspen; 1995. p. 145-69.
43. Mills WJ, Pozos RS. A decrease in clonus amplitude by topical anesthesia. Electroencephalogr Clin Neurophysiol 1985;61:509-18.
44. Sabbahi MA, De Luca CJ, Powers WR. Topical anesthesia: a possible treatment method for spasticity. Arch Phys Med Rehabil 1981;62:310-4.
45. Pinder RM, Brogden RN, Speight TM, Avery GS. Dantrolene sodium: a review of its pharmacological properties and therapeutic efficacy in spasticity. Drugs 1977;13:3-23.
46. Dengler R, Neyer U, Wolfarth K, Bettig U, Janzik HH. Local botulinum toxin in the treatment of spastic drop foot. J Neurol 1992;239:375-8.
47. Hesse S, Krajnik J, Luecke D, Jahnke MT, Gregoric M, Mauritz KH. Ankle muscle activity before and after botulinum toxin therapy for lower limb extensor spasticity in chronic hemiparetic patients. Stroke 1996;27:455-60.
48. Davidoff RA. Antispasticity drugs: mechanisms of action. Ann Neurol 1985;17:107-16.
49. Mondrup K, Pedersen E. The effect of the GABA-agonist, progabide, on stretch and flexor reflexes and on voluntary power in spastic patients. Acta Neurol Scand 1984;69:191-9.
50. Albright AL, Barron WB, Fasick MP, Polinko P, Janosky J. Continuous intrathecal baclofen infusion for spasticity of cerebral origin. JAMA 1993;270:2475-7.
51. Coffey RJ, Cahill D, Steers W, Parks TS, Ordia J, Meythaler J, et al. Intrathecal baclofen for intractable spasticity of spinal origin - results of a long-term multicenter study. J Neurosurg 1993;78: 226-32.
52. Lazorthes Y, Verdié J-C, Sallerin-Caute B, Bastide R. Intrathecal infusion of baclofen for spasticity: the Toulouse and the French multicenter studies. In: Sindou M, Abbott IR, Keravel Y editors. Neurosurgery for spasticity. New York: Springer-Verlag; 1991. p. 111-16.
53. Loubser PG, Narayan RK, Sandin KJ, Donovan WH, Russell KD. Continuous infusion of intrathecal baclofen: long-term effects on spasticity in spinal cord injury. Paraplegia 1991;29:48-64.
54. Müller H, Zierski J, Dralle D, Borner U, Hoffmann O. The effect of intrathecal baclofen on electrical muscle activity in spasticity. J Neurol 1987;234:348-52.
55. Ochs G, Struppler A, Meyerson BA, Linderoth B, Gybels J, Gardner BP, et al. Intrathecal baclofen for long-term treatment of spasticity: a multicenter study. J Neurol Neurosurg Psychiatry 1989;52:933-9.
56. Penn RD. Intrathecal baclofen for spasticity of spinal origin: seven years of experience. J Neurosurg 1992;77:236-40.
57. Penn RD, Kroin JS. Long-term intrathecal baclofen infusion for treatment of spasticity. J Neurosurg 1987;66:181-85.
58. Penn RD, Savoy SM, Corcos D, Latash M, Gottlieb G, Parke B, et al. Intrathecal baclofen for severe spinal spasticity. N Engl J Med 1989;320:1517-21.
59. Campbell SK, Almeida GL, Penn RD, Corcos DM. The effects of intrathecally administered baclofen on function in patients with spasticity. Phys Ther 1995;75:352-62.
60. Lewis KS, Mueller WM. Intrathecal baclofen for severe spasticity secondary to spinal cord injury. Ann Pharmacother 1993;27: 767-74.
61. Ochs GA. Intrathecal baclofen. Baillières Clin Neurol 1993;2:73-86.
62. Stern P, Bokonjic R. Glycine therapy in 7 cases of spasticity. Pharmacology 1974;12:117-9.
63. Lee A, Patterson V. A double-blind study of 1-threonine in patients with spinal spasticity. Acta Neurol Scand 1993;88:334-8.
64. Erickson DL, Blacklock JB, Michaelson M, Sperling KB, Lo JN. Control of spasticity by implantable continuous flow morphine pump. Neurosurgery 1985;16:215-7.
65. Whyte J, Robinson KM. Pharmacologic management. In: Glenn MB, Whyte J, editors. The practical management of spasticity in children and adults. Malvern (PA): Lea & Febiger; 1990. p. 201-26.
66. Mai J, Pedersen E. Clonus depression by propranolol. Acta Neurol Scand 1976;53:395-8.
67. Coward D. Tizanidine - neuropharmacology and mechanism of action. Neurology 1994;44(11 Suppl 9):6-11.
68. Bass B, Weinshenker B, Rice GPA, Noseworthy JH, Cameron MGP, Hader W, et al. Tizanidine versus baclofen in the treatment of spasticity in patients with multiple sclerosis. Can J Neurol Sci 1988;15:15-19.
69. Maynard FM. Early clinical experience with clonidine in spinal spasticity. Paraplegia 1986;24:175-82.
70. Donovan WH, Carter RE, Rossi CD, Wilkerson MA. Clonidine effect on spasticity: a clinical trial. Arch Phys Med Rehabil 1988;69:193-4.
71. Weingarden SI; Belen JG. Clonidine transdermal system for treatment of spasticity in spinal cord injury. Arch Phys Med Rehabil 1992;73:876-7.
72. Barbeau H, Richards CL, Bédard PJ. Action of cyproheptadine in spastic paraparetic patients. J Neurol Neurosurg Psychiatry 1982;45:923-6.
73. Nance PW. A comparison of clonidine, cyproheptadine and baclofen in spastic spinal cord injured patients. J Am Paraplegia Soc 1994;17:150-6.
74. Forssberg H, Grillner S. The locomotion of the acute spinal cat injected with clonidine i.v. Brain Res 1973;50:184-6.
75. Rossignol S, Barbeau H, Julien C. Locomotion of the adult chronic spinal cat and its modification by monoaminergic agonists and antagonists. In: Goldberger ME. Gorio A, Murray M, editors. Development and plasticity of the mammalian spinal cord. Padova, Italy: Liviana; 1986. p. 323-45.
76. Barbeau H, Rossignol S. Initiation and modulation of the locomotor pattern in the adult chronic spinal cat by noradrenergic, serotonergic and dopaminergic drugs. Brain Res 1991;546: 250-60.
77. Rossignol S, Barbeau H, Provencher J. Locomotion in the adult chronic spinal cat. Soc Neurosci Abstr 1982;8:163.
78. Barbeau H, Julien C, Rossignol S. The effects of clonidine and yohimbine on locomotion and cutaneous reflexes in the adult chronic spinal cat. Brain Res 1987;437:83-96.
79. Rossignol S, Chau C, Barbeau H. Pharmacology of locomotion in chronic spinal cats. In: Taylor A, Gladden MH, Durbaba R, editors. Alpha and gamma motor systems. New York: Plenum; 1996. p. 449-55.
80. Corston RN, Johnson F, Godwin-Austen RB. The assessment of drug treatment of spastic gait. J Neurol Neurosurg Psychiatry 1981;44:1035-9.
81. Stewart JE, Barbeau H, Gauthier S. Modulation of locomotor patterns and spasticity with clonidine in spinal cord injured patients. Can J Neurol Sci 1991;18:321-32.
82. Dietz V, Colombo G, Jensen L, Baumgartner L. Locomotor capacity of spinal cord in paraplegic patients. Ann Neurol 1995;37:574-82.
83. Bastings E, Rapisarda G, Pepin JL, Delwaide PJ. Nouvelles approaches pharmacologiques du traitement des troubles de la marche consecutifs à une lésion spinale. Rev Med Liège 1995;50: 204-8.
84. Knutsson E. Analysis of gait and isokinetic movements for evaluation of antispastic drugs or physical therapies. Adv Neurol 1983;39:1013-34.
85. Rémy-Neris O, Thiebaut JB, Boiteau F, Bussel B, Barbeau H. The effects of intrathecal clonidine on spinal reflexes and on locomotion in incomplete paraplegic subjects [abstract]. Eur J Neurosci 1996;8:76.
86. Barbeau H, Rossignol S. The effects of serotonergic drugs on the locomotor pattern and on cutaneous reflexes of the adult chronic spinal cat. Brain Res 1990;514:55-67.
87. Wainberg M, Barbeau H, Gauthier S. The effects of cyproheptadine on locomotion and on spasticity in patients with spinal cord injuries. J Neurol Neurosurg Psychiatry 1990;53:754-63.
88. Penn RD. Intrathecal baclofen for severe spasticity. Ann N Y Acad Sci 1988;531:157-66.
89. Broseta J, Morales F, Garcia-March G, Sánchez-Ledesma MJ, Anaya J, Gonzalez-Darder J, et al. Use of intrathecal baclofen administered by programmable infusion pumps in resistant spasticity. Acta Neurochir Suppl 1989;46:39-45.
90. Lazorthes Y, Sallerin-Caute B, Verdié J-C, Bastide R, Carillo J-P. Chronic intrathecal baclofen administration for control of severe spasticity. J Neurosurg 1990;72:393-402.
91. Sahuquillo J, Muxi T, Noguer M, Jodar R, Closa C, Rubio E, et al. Intraspinal baclofen in the treatment of severe spasticity and spasms. Acta Neurochir (Wien) 1991;110:166-73.
92. Saltuari L, Kronenberg M, Marosi MJ, Kofler M, Russegger L, Rifici C, et al. Indication, efficiency and complications of intrathecal pump supported baclofen treatment in spinal spasticity. Acta Neurol (Napoli) 1992;14:187-94.
93. Meythaler JM, Steers WD, Tuel SM, Cross LL, Sesco DC, Haworth CS. Intrathecal baclofen in hereditary spastic paraparesis. Arch Phys Med Rehabil 1992;73:794-7.
94. Abel NA, Smith RA. Intrathecal baclofen for treatment of intractable spinal spasticity. Arch Phys Med Rehabil 1994;75: 54-8.
95. Azouvi P, Mane M, Thiebaut JB, Denys P, Rémy-Neris O, Bussel B. Intrathecal baclofen administration for control of severe spinal spasticity: functional improvement and long-term follow-up. Arch Phys Med Rehabil 1996;77:35-9.
96. Chau C, Provencher J, Lebel F, Barbeau H, Rossignol S. Effects of GABAergic drugs on locomotion in adult chronic spinal cats. Soc Neurosci Abstr 1995;21:420.
97. Cazalets JR, Sqalli-Houssaini, Clarac F. GABAergic inactivation of the central pattern generators for locomotion in isolated neonatal rat spinal cord. J Physiol (Lond) 1994;474:473-81.
98. A and GABAB receptors. J Neurophysiol 1993;69:647-57.
99. Rossignol S, Dubuc R. Spinal pattern generation. Curr Opin Neurobiol 1994;4:894-902.
100. Rossignol S, Chau C, Brustein E, Bélanger M, Barbeau H, Drew T. Locomotor capabilities after complete and partial lesions of the spinal cord. Acta Neurobiol Exp (Warsz) 1996;56:449-63.
101. Grillner S. Locomotion in the spinal cat. In: Stein RB, Pearson KG, Smith RS, Bedford JB, editors. Control of posture and locomotion. New York: Plenum; 1973. p. 515-35.
102. Forssberg H, Grillner S, Halbertsma J. The locomotion of the low spinal cat. I. Coordination within a hindlimb. Acta Physiol Scand 1980;108:269-81.
103. Smith JL, Smith LA, Zernicke RF, Hoy M. Locomotion in exercised and nonexercised cats cordotomized at two or twelve weeks of age. Exp Neurol 1982;76:393-413.
104. Eidelberg E, Story JL, Meyer BL, Nystel J. Stepping by chronic spinal cats. Exp Brain Res 1980;40:241-6.
105. Barbeau H, Rossignol S. Recovery of locomotion after chronic spinalization in the adult cat. Brain Res 1987;412:84-95.
106. Bélanger M, Drew T, Provencher J, Rossignol S. A comparison of treadmill locomotion in adult cats before and after spinal transection. J Neurophysiol 1996;76:471-91.
107. Engberg I, Lundberg A. An electromyographic analysis of muscular activity in the hindlimb of the cat during unrestrained locomotion. Acta Physiol Scand 1969;75:614-30.
108. Lovely RG, Gregor RJ, Roy RR, Edgerton VR. Effects of training on the recovery of full-weight bearing stepping in the adult spinal cat. Exp Neurol 1986;92:421-35.
109. Edgerton VR, de Guzman CP, Gregor RJ, Roy RR, Hodgson JA, Lovely RG. Trainability of the spinal cord to generate hindlimb stepping patterns in adult spinalized cats. In: Shimamura M, Grillner S, Edgerton VR, editors. Neurobiological basis of human locomotion. Tokyo: Japan Scientific Society; 1991. p. 411-23.
110. Gazzani F, Macellari V, Torre M, Castellano V, Coratella D. WARD: a pneumatic system for body weight relief in gait rehabilitation. In: Proceedings of the Annual International Conference of the IEEE Engineering in Medicine and Biology Society; 1996 Oct 31-Nov 3; Amsterdam. Piscataway (NJ): IEEE; 1996. p. 861.
111. Barbeau H, Wainberg M, Finch L. Description and application of a system for locomotor rehabilitation. Med Biol Eng Comput 1987;25:341-4.
112. Norman KE, Pepin A, Ladouceur M, Barbeau H. A treadmill apparatus and harness support for evaluation and rehabilitation of gait. Arch Phys Med Rehabil 1995;76:772-8.
113. He JP, Kram R, McMahon TA. Mechanics of running under simulated low gravity. J Appl Physiol 1991;71:863-70.
114. Siddiqi N, Gazzani F, Chen M, Ide T, Campbell K, Chao EYS. Effects of robot-assisted weight support on ambulation and mobility exercises. Adv Bioeng 1994;28:247-8.
115. Visintin M, Barbeau H. The effects of body weight support on the locomotor pattern of spastic paretic patients. Can J Neurol Sci 1989;16:315-25.
116. Barbeau H, Danakas M, Arsenault B. The effects of locomotor training in spinal cord injured subjects - a preliminary study. Restor Neurol Neurosci 1993;5:81-4.
117. Dobkin BH, Edgerton VR, Fowler E, Hodgson J. Training induces rhythmic locomotor EMG patterns in a subject with complete spinal cord injury. Neurology 1992;42(3 Suppl):207-8.
118. Wernig A, Müller S. Laufband locomotion with body weight support improved walking in persons with severe spinal cord injuries. Paraplegia 1992;30:229-38.
119. Hesse S, Bertelt C, Schaffrin A, Malezic M, Mauritz K-H. Restoration of gait in nonambulatory hemiparetic patients by treadmill training with partial body-weight support. Arch Phys Med Rehabil 1994;75:1087-93.
120. Liberson WT, Holmquest HJ, Scott D, Dow A. Functional electrotherapy: stimulation of the peroneal nerve synchronized with the swing phase of the gait in hemiplegic patients. Arch Phys Med Rehabil 1961;42:101-5.
121. Kantrowitz A. Electronic physiologic aids. Brooklyn (NY): Maimonides Hospital; 1963.
122. Yarkony GM, Roth EJ, Cybulski G, Jaeger RJ. Neuromuscular stimulation in spinal cord injury I: Restoration of functional movement of the extremities. Arch Phys Med Rehabil 1992;73:78-86.
123. Bajd Y, Kralj A, Turk H, Benko H, Sega J. Use of functional electrical stimulation in the rehabilitation of patients with incomplete spinal cord injuries. J Biomed Eng 1989;11:96-102.
124. Stein RB, Bélanger M, Wheeler G, Wieler M, Popovic D, Prochazka A, et al. Electrical systems for improving locomotion after incomplete spinal cord injury: an assessment. Arch Phys Med Rehabil 1993;74:954-9.
125. Granat M, Keating JF, Smith AC, Delargy M, Andrews BJ. The use of functional electrical stimulation to assist gait in patients with incomplete spinal cord injury. Disabil Rehabil 1992;14: 93-7.
126. Wieler M, Stein RB, Dai R. Multi-center clinical testing of functional electrical stimulation systems to assist walking [abstract]. In: Proceedings of the 12th International Congress of the World Confederation for Physical Therapy; 1995 June 25-30; Washington, DC. Washington (DC): American Physical Therapy Association; 1995. p. 773.
127. Ladouceur M, Pépin A, Norman KE, Barbeau H. Recovery of walking after spinal cord injury. Adv Neurol 1997;72:249-55.
128. Granat MH, Ferguson ACB, Andrews BJ, Delargy M. The role of functional electrical stimulation in the rehabilitation of patients with incomplete spinal cord injury: observed benefits during gait studies. Paraplegia 1993;31:207-15.
129. Ladouceur M, Chilco L, Barbeau H. Amélioration de la marche chez le blessé médullaire incomplet (BMI) lors d'un programme d'entraînement àla marche assisté par stimulation électrique fonctionnelle (SEF). 10th Annual Spinal Cord Injury Research Symposium; 1994 Sept 27: Montréal, Canada.
130. Intiso D, Santilli V, Grasso MG, Rossi R, Caruso I. Rehabilitation of walking with electromyographic biofeedback in foot-drop after stroke. Stroke 1994;25:1189-92.
131. Mandel AR, Nymark JR, Balmer SJ, Grinnell DM, O'Riain MD. Electromyographic versus rhythmic positional biofeedback in computerized gait retraining with stroke patients. Arch Phys Med Rehab 1990;71:649-54.
132. Montoya R, Dupui P, Pages B, Bessou P. Step-length biofeedback device for walk rehabilitation. Med Biol Eng Comp 1994;32:416-20.
133. Cozean CD, Pease WS, Hubbell SL. Biofeedback and functional electric stimulation in stroke rehabilitation. Arch Phys Med Rehabil 1988;69:401-5.
134. Brucker BS, Bulaeva NV. Biofeedback effect on electromyography responses in patients with spinal cord injury. Arch Phys Med Rehabil 1996;77:133-7.
135. Nene AV, Hermens HJ, Zilvold G. Paraplegic locomotion: a review. Spinal Cord 1996;34:507-24.
136. Barbeau H, Chau C, Rossignol S. Noradrenergic agonists and locomotor training affect locomotor recovery after cord transection in adult cats. Brain Res Bull 1993;30:387-93.
137. Fung J, Stewart JE, Barbeau H. The combined effects of clonidine and cyproheptadine with interactive training on the modulation of locomotion in spinal cord injured subjects. J Neurol Sci 1990;100: 85-93.
138. Muybridge E. Animal locomotion. Philadelphia (PA): University of Pennsylvania; 1887.
139. Sherrington CS. The integrative action of the nervous system. New Haven (CT): Yale University; 1906.
140. Brown TG. The intrinsic factors in the act of progression in the mammal. Proc R Soc London Ser B 1911;84:308-19.
141. Bernshtein N. The coordination and regulation of movements. Oxford: Pergamon; 1967.
142. Winter DA. Sagittal planc balance and posture in human walking. IEEE Eng Med Biol 1987;8:8-11.
143. Forssberg H. Spinal locomotor functions and descending control. In: Sjölund B, Björklund A, editors. Brain stem control of spinal mechanisms. Amsterdam: Elsevier Biomedical; 1982. p. 253-71.
144. Winter DA. Energy generation and absorption at the ankle and knee during fast, natural and slow cadences. Clin Orthop Rel Res 1983;175:147-54.
145. Kuster M, Sakurai S, Wood GA. Kinematics and kinetics of downhill versus level walking. In: Proceedings of the XIV Congress of the International Society of Biomechanics, 1993, Paris. Cleveland (OH): ISB; 1993. p. 732-3.
146. McFadyen BJ, Winter DA. Anticipatory locomotor adjustments during obstructed human walking. Neurosci Res Comm 1991;9: 37-44.
147. Patla AE, Prentice SD, Robinson C, Neufeld J. Visual control of locomotion: strategies for changing direction and for going over obstacles. J Exp Psychol Hum Percept 1991;17:603-34.
148. Ladouceur M, Barbeau H. Anticipatory locomotor adjustments of spastic paretic subjects during obstructed overground walking. Soc Neurosci Abstr 1993;19:554.
149. Ladouceur M, Norman KE, Barbeau H. Combination of rehabilitation strategies for the recovery of walking after spinal cord injury. Can J Rehabil 1993;7:20-2.
150. Dietz V. Gating of reflexes in ankle muscles during human stance and gait. Prog Brain Res 1993;97:181-8.
151. Hoffer M, Feiwell E, Perry R, Perry J, Bonnett C. Functional ambulation in patients with myelomeningocele. J Borie Joint Surg 1973;55:137-48.
152. Perry J, Garret M, Gronley JK, Mulroy SJ. Classification of walking handicap in the stroke population. Stroke 1995;27:982-9.
153. Barbeau H, Pepin A, Norman KE, Ladouleur M, Leroux A. Walking after spinal cord injury. Neuroscientist 1998;4:14-24.